Systemic antifungal therapy in critically ill patients without invasive fungal infection
Elie Azoulay, Herve Dupont, Alexis Tabah, et al, on behalf of the French Society for Critical Care (SRLF) in Collaboration With the French Society for Infectious Diseases (SPILF) and the French Society for Anesthesia and Intensive Care (SFAR)
Crit Care Med, 2012, 40:813
This page is only available to Crit-IQ subscribers. To view the rest of this review and gain access to our vast array of critical care teaching tools including podcasts, vodcasts, modules,
exam preparation tools, teaching aids and much more, login here, or Become a Member to register
|
March
|
Comment
This observational multi-centre study on use of systemic antifungals, from Belgium and France, offers a number of lessons. Firstly it provides a good review of the risk factors and incidence of systemic anti fungal infection in critical illness.
Secondly it observes that ;
-...